Abstract
We consider a proteomic mass spectrometry case-control study for the calibration of a diagnostic rule for the detection of early-stage breast cancer. For each patient, a pair of two distinct mass spectra is recorded, each of which is derived from a different prior fractionation procedure on the available patient serum. We propose a procedure for combining the distinct spectral expressions from patients for the calibration of a diagnostic discriminant rule. This is achieved by first calibrating two distinct prediction rules separately, each on only one of the two available spectral data sources. A double cross-validatory approach is used to summarize the available spectral data using the two classifiers to posterior class probabilities, on which a combined predictor can be calibrated. © 2011 Elsevier B.V.
| Original language | English |
|---|---|
| Pages (from-to) | 759-766 |
| Number of pages | 8 |
| Journal | Statistics & probability letters |
| Volume | 81 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - Jul 2011 |
| Externally published | Yes |
Keywords
- Clinical mass spectrometry proteomics
- Predictive data fusion
- Double cross-validation
- Classification
- Model combination
- MALDI-TOF
- SPECTROMETRY
Fingerprint
Dive into the research topics of 'On the use of double cross-validation for the combination of proteomic mass spectral data for enhanced diagnosis and prediction'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver